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Background: Inmultiple sclerosis (MS), brain atrophy quantiﬁcation is affected bywhitematter lesions. LEAP and
FSL-lesion_ﬁlling, replace lesion voxels with white matter intensities; however, they require precise lesion
identiﬁcation on 3DT1-images.
Aim: To determine whether 2DT2 lesion masks co-registered to 3DT1 images, yield grey and white matter
volumes comparable to precise lesion masks.
Methods: 2DT2 lesion masks were linearly co-registered to 20 3DT1-images of MS patients, with nearest-
neighbor (NNI), and tri-linear interpolation. As gold-standard, lesion masks were manually outlined on 3DT1-
images. LEAP and FSL-lesion_ﬁlling were applied with each lesion mask. Grey (GM) and white matter (WM)
volumes were quantiﬁed with FSL-FAST, and deep gray matter (DGM) volumes using FSL-FIRST. Volumes were
compared between lesion mask types using paired Wilcoxon tests.
Results: Lesion-ﬁlling with gold-standard lesion masks compared to native images reduced GM overestimation
by 1.93 mL (p b .001) for LEAP, and 1.21 mL (p = .002) for FSL-lesion_ﬁlling. Similar effects were achieved
with NNI lesion masks from 2DT2. Global WM underestimation was not signiﬁcantly inﬂuenced. GM and WM
volumes from NNI, did not differ signiﬁcantly from gold-standard. GM segmentation differed between lesion
masks in the lesion area, and also elsewhere. Using the gold-standard, FSL-FAST quantiﬁed as GM on average
0.4% of the lesion areawith LEAP and 24.5%with FSL-lesion_ﬁlling. Lesion-ﬁlling did not inﬂuence DGM volumes
from FSL-FIRST.
Discussion: These results demonstrate that for global GM volumetry, precise lesionmasks on 3DT1 images can be
replaced by co-registered 2DT2 lesion masks. This makes lesion-ﬁlling a feasible method for GM atrophy
measurements in MS.© 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
In the multiple sclerosis (MS) brain, volume loss or “atrophy” of the
grey (GM) and white matter (WM) has been observed (Benedict et al.,
2005; De Stefano et al., 2007; Fisher et al., 2008; Miller et al., 2002;
Minneboo et al., 2008).While 3DT1-weighted imageswith thin sections
are highly suitable for quantifying the GM andWM volumes, the white
matter MS lesions are also visible on these images as signal hypo-
intensities, affecting most automated image segmentation methods
(Battaglini et al., 2012; Chard et al., 2010; Nakamura and Fisher, 2009;
Sdika and Pelletier, 2009). Three recent methods circumvent thiserms of the Creative Commons
which permits non-commercial
d the original author and source
gy and Nuclear Medicine, De
lished by Elsevier Inc. All rights reserproblemby replacing (“ﬁlling”) lesion voxelswithwhitematter intensi-
ties (Battaglini et al., 2012; Chard et al., 2010; Sdika and Pelletier, 2009)
on images with simulated lesions, yielding segmentations as if lesions
were absent. Although these methods are able to reduce theWM lesion
inﬂuence on atrophy measurements, they require outlining of the
lesions on 3DT1 images. In the absence of satisfactory automated WM
lesion segmentation methods (Garcia-Lorenzo et al., 2013; Llado et al.,
2012), these outlines have to be generated manually on the large num-
ber of sections for each 3DT1 image volume, which is labor-intensive
and therefore too costly for large studies. As a result, the lesion-ﬁlling
methods are currently not used to their full potential. By contrast,
many clinical trials and academic studies do generate manual lesion
masks for 2D dual-echo images, which normally have thicker slices
(e.g. 3 mm compared to 1 mm of the 3DT1 sections). If these 2D lesion
masks could be used instead of manual 3D lesion masks, lesion-ﬁlling
could be applied in large studies to achieve improved quantiﬁcation of
tissue-speciﬁc atrophy without the prohibitive cost of precise 3D man-
ual outlining.ved.
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lesion-ﬁllingwith co-registeredWM lesionmasks from 2DT2-weighted
images. By using two interpolation methods and a range of thresholds,
we created different versions of the co-registered 2DT2 lesion masks.
We then applied lesion-ﬁlling to the corresponding regions of the
3DT1 images, using two methods: the “LEAP” method (Chard et al.,
2010) and FSL-lesion_ﬁlling (Battaglini et al., 2012). For each resulting
image we quantiﬁed tissue volumes using FSL-FAST and FSL-FIRST,
and assessed agreement of the resulting global GM and WM volumes
and deep GM volumes with those obtained using gold-standard 3D
lesion masks. Additionally, we investigated whether the observed dif-
ferences on the voxelwise GM segmentations from FSL-FAST occurred
inside lesion areas, in other regions, or both.2. Materials and methods
Theﬂowchart in Fig. 1 illustrates ourworkﬂow. FSL version 5.0.4was
used for the processing.Fig. 1. Flow-chart of the2.1. Patients and images
Previously acquired 3DT1 image volumeswere selected froma total of
20 MS patients (center A: 10 patients, 3 T; center B: 10 patients, 1.5 T).
Ethics committee approval and informed consent were obtained from
the patients for the original study in which they participated. The image
acquisition parameters and clinical data of the patients are listed in
Table 1.2.2. 2DT2 lesion masks
We collected the 2DT2 lesionmasks that had already beenmanually
outlined for the original study in the participating centers. Using FLIRT
(Jenkinson et al., 2002), the 2DT2-weighted images were linearly regis-
tered to 3DT1 images, both with nearest neighbor (NNI) and tri-linear
interpolation (TLI) and the transformation matrix applied to the lesion
masks obtained on the 2DT2-weighted scans. To the registered TLI
masks, we additionally applied a range of thresholds between 0 and 1,image processing.
Table 1
Descriptive values per center reported as median (interquartile range IQR).
Amsterdam London
Nr. patients (women) 10 (4) 10 (5)
Age (years) median (IQR) 44 (32–48) 34 (30–44)
Disease typea 9 RRMS, 1 SPMS 10 RRMS
Disease duration (years) median (IQR) 8 (8–9) 2 (1.5-2.5)
EDSSb 1.5 (1–4.25) 1.5 (1–2)
Disease modifying treatment 5 patients -
NBV on gold-standard ﬁlled images (L)c median (IQR) 1.43 (1.48-1.53) 1. 54 (1.48-1.58)
Lesion load (mL) median (IQR)d 1.2 (0.52-4.55) 6.27 (2.21-15.99)
Lesion numbers median (IQR)d 21 (16–40) 15 (10–22)
3DT1 hypointense lesion volume (mL) median (IQR) 1.55 (0.9-4.3) 6 (2–11.1)
3DT1 hypointense lesion numbers median (IQR) 20 (16–42) 15 (9–31)
Field strength (T) 3.0 1.5
3D-T1 voxel size (mm) Sagittal 0.97/0.97/1 Axial 1.17/1.17/1.5
PDT2 voxel size (mm) 0.5/0.5/3 0.9/0.9/5
a RRMS= relapsing-remitting multiple sclerosis SPMS = secondary progressive multiple sclerosis.
b EDSS = Expanded Disability Status Scale.
c NBV = Normalized Brain Volume (calculated with FSL-SIENAX).
d Lesion load (lesion numbers) = lesion volume (lesion numbers) on the 2DT2 lesion masks that had already been manually outlined for the original study
in the participating centers.
Fig. 2. Axial view of 3DT1 image and different lesion masks for a 47-years old, male RRMS patient scanned at 3 T. From left to right: Image with no lesion masks. Image with precise
manual lesion masks (yellow). Image with nearest neighbor registered lesion masks (dark blue). Image with trilinearly registered lesion masks with different thresholds: light blue:
threshold = 0.2; red: threshold = 0.5; pink: threshold = 0.8.
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with the NNI lesion masks, this yielded 12 different versions of 3DT1-
co-registered lesion masks derived from the 2DT2 lesion masks. All
the registered masks were visually checked for registration errors.
2.3. 3D lesion masks
Gold-standard 3D lesion masks were manually outlined by a single
observer (NCGR) on 3DT1 images by adjusting the contours of the
2DT2 lesion masks after registering them to the 3DT1 images. In the
rare occurrence where a 2D lesion did not correspond to a 3DT1
hypointense area, the lesion contour was not deleted, but still consid-
ered a lesional area. The lesion masks were all inspected for correctness
by VP.
2.4. Lesion ﬁlling
For each of the 13 different lesion mask versions (12 co-registered
and the gold standard set), images underwent lesion-ﬁlling with two
methods.
The ﬁrst lesion-ﬁlling method is LEAP, described in detail elsewhere
(Chard et al., 2010). Brieﬂy, LEAP separates brain from non-brain tissue
(Smith, 2002), corrects image non-uniformity using N3 (Sled, 1997),
generates a simulated WM image without any lesions based on the
noise and signal inhomogeneity of the original image, and ﬁnallyFig. 3. Images after lesionﬁllingwith LEAP (row1) and FSL-lesion_ﬁlling (row2). Rows 3 and 4:
(row 4). Rows 5 and 6: white matter (WM) segmentation after lesion ﬁlling with LEAP (row
manual lesion masks; image with nearest neighbor registered lesion masks; image with trilin
and are depicted below.replaces the original intensity values within the lesion masks with in-
tensity values taken from corresponding locations in the simulated
WM image.
The second method used for lesion-ﬁlling was FSL-lesion_ﬁlling
(Battaglini et al., 2012). Brieﬂy, this ﬁlls lesion mask voxels with inten-
sities based on the neighboring non-lesion voxels of the lesion masks.
2.5. Quantiﬁcation of volumes
For each patient, brain tissue volumes were quantiﬁed from the fol-
lowing 27 image volumes: the native (non-ﬁlled) 3DT1 image volume;
the set of thirteen 3DT1 image volumes obtained after lesion-ﬁllingwith
LEAP using the different lesion masks; and the set of thirteen 3DT1
image volumes obtained after lesion-ﬁlling with FSL-lesion_ﬁlling
using the different lesion masks (see Fig. 1 for the ﬂowchart illustrating
this).
In each case, we ﬁrst removed non-brain tissue using BET, with
optimized parameters as previously described (Popescu et al., 2012).
Next, global GM andWMvolumeswere quantiﬁed using the partial vol-
ume estimation within FSL-FAST (Smith et al., 2004); and deep grey
matter (DGM) volumes were calculated using FSL-FIRST (Patenaude
et al., 2011); speciﬁcally, volumeswere obtained for the following struc-
tures: brainstem, and bilateral putamen, caudate nucleus, thalamus, pu-
tamen, hippocampus, amygdala, and nucleus accumbens. Bilateral
volumes of GM structures were averaged. The GM and WM volumesgreymatter (GM) segmentation after lesionﬁllingwith LEAP (row3) and FSL-lesion_ﬁlling
5) and FSL-lesion_ﬁlling (row 6). From left to right: no lesion masks; image with precise
early registered lesion masks threshold=0.5. The color scales are the same for all images
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they would also include the misclassiﬁed voxels.
Brain tissue volume, normalized for subject head size (NBV), was
estimated with SIENAX (Smith et al., 2002) part of FSL (Smith et al.,
2004).
2.6. Statistics
For each of the two lesion-ﬁlling methods (LEAP and FSL-
lesion_ﬁlling), we compared the GM, WM and DGM volumes obtain-
ed using each version of the co-registered lesion masks and the
native images to the corresponding values obtained when using the
gold-standard lesion masks using paired Wilcoxon signed ranks
test. The signiﬁcance level was p b 0.05.
3. Results
Fig. 2 shows an MRI image example before lesion ﬁlling with no
lesion masks, with superimposed gold-standard masks, NNI registered
lesion masks and TLI registered lesion masks with different thresholds.
As expected, co-registered lesion masks do not overlap perfectly with
3DT1 lesion areas.
3.1. Global GMandWMvolumes from FSL-FAST voxelwise PVE segmentation
The native images, images after lesion ﬁlling (with LEAP and
FSL-lesion_ﬁlling) and the GM and WM segmentation of these images
are depicted in Fig. 3.
Fig. 4 shows the boxplots of the global GMandWMvolumes for each
of the lesion mask types and for the native images. SupplementaryFig. 4. Boxplots of the relative error in grey matter (GM) volumes (a, b) and white matter (WM
lesion masks using LEAP for lesion ﬁlling (a, c) and FSL lesion_ﬁlling (b, d). The GM and WM
ﬁlling the gold-standard (manual) lesion masks and then applying FSL-FAST segmentation. N
masks. TLI = after ﬁlling with trilinearly co-registered masks and then thresholding with the ieTable 1 lists these results and Supplementary eTable 2 the DGM
volumes. Lesion-ﬁlling with LEAP using gold-standard lesion masks
resulted in smaller global GM volumes compared to native images
(1.93 mL, p b .001). Conversely, globalWM volumes were not different
using lesion ﬁlling with gold-standard lesion masks compared to native
images (0.2 mL, p = .7). For lesion ﬁlling with FSL-lesion_ﬁlling,
very similar results were observed for both GM and WM volumes
(Supplementary eTable 1).
For both LEAP lesion ﬁlling and FSL-lesion_ﬁlling, GM volumes
from FSL-FAST measured on images ﬁlled with NNI masks were not
statistically different from the GM volumes obtained from the gold-
standard segmentation (p = .232 and p = .279 respectively). For FSL-
lesion_ﬁlling, lesion masks obtained through tri-linear interpolation
and subsequent thresholding showed a trend towards underestimation
of global GM volume for low thresholds, and overestimation of global
GM volume for higher thresholds. For LEAP, these same lesion masks
resulted in less consistent behavior regarding the resulting global GM
volumes (Fig. 4).3.2. Deep GM volumes from FSL-FIRST
In this sample, the DGMvolumes quantiﬁed by FSL-FIRST did not dif-
fer between the native images and the images ﬁlled using gold-standard
lesion masks (Supplementary eTable 2), neither for LEAP nor for
FSL-lesion_ﬁlling. In line with this, there were also no differences for
any of the co-registered lesion masks for either lesion ﬁlling method
(Supplementary eTable 2): p-values for the different DGM structures
were between .232 and .526 for LEAP, and between .145 and .911 for
FSL-lesion_ﬁlling. To illustrate this, Fig. 5 shows the boxplots of the
relative error in mean bilateral thalamic volumes.) volumes (c, d) from segmentation of images after ﬁlling lesions obtained with different
volumes are reported as percentual difference relative to the GM volume obtained after
ative = native (unﬁlled) images. NNI = after ﬁlling with nearest-neighbor co-registered
ndicated value.
Fig. 5. Boxplots of the relative error inmean bilateral thalamic volumes from segmentation of images after ﬁlling lesions obtained with different lesion masks using LEAP for lesion ﬁlling
(a) and FSL lesion_ﬁlling (b). The thalamic volumes are reported as percentual difference relative to the thalamic volume obtained after ﬁlling the gold-standard (manual) lesion masks
and then applying FSL-FAST segmentation. Native = native (unﬁlled) images. NNI = after ﬁlling with nearest-neighbor co-registered masks. TLI = after ﬁlling with trilinearly
co-registered masks and then thresholding with the indicated value. These graphs are similar to the behavior of the other DGM structures both with LEAP lesion ﬁlling as well as with
FSL-lesion_ﬁlling.
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Because signiﬁcant global GM volume differences were observed
from the analysis of FSL-FAST voxelwise segmentations, we analyzed
whether these differences were mainly localized in lesion areas, or
also elsewhere in the brain. The differences were located both insideFig. 6. Location of grey matter (GM) differences (mm3) to gold-standard lesion-ﬁlling with LE
lesion volume. Above the native images compared to gold-standard and below the images ﬁ
with diamond-shaped markers is depicted the total GM difference from gold-standard, in red
markers the difference outside of the lesion area.and outside of the lesion area as visible in Fig. 6. With increasing lesion
volumes, the overestimation of total GM volume increases. Interesting-
ly, GM overestimation inside lesion areas is partially offset by an under-
estimation outside the lesion areas. Both effects show a tendency to
increase with increasing lesion volumes (Fig. 6 panels A and B). These
effects were observed for both lesion ﬁlling methods, though to aAP (left column) and FSL-lesion-ﬁlling (right column) as a function of the gold-standard
lled with nearest-neighbor registered masks (NNI) compared to gold-standard. In blue
with square markers the difference within the lesion area and in green with triangular
372 V. Popescu et al. / NeuroImage: Clinical 4 (2014) 366–373slightly smaller extent for FSL-lesion_ﬁlling. When using NNI masks
these effects were markedly reduced and much better agreement with
gold-standard results was achieved across the range of lesion volumes
(Fig. 6 panels C and D).
The NNI lesion masks did not overlap perfectly with 3DT1 lesion
areas; there were 42% false positive voxels (averaged across patients)
compared to gold-standard and 60% false negative voxels (averaged
across patients) compared to gold-standard. But after FSL-FAST
segmentation only 0.17% of the segmented GM was found within
the false negative voxels and 0.03% within the false positive voxels
(Fig. 7). The percentage of false positive voxels compared to gold-
standardwas not signiﬁcantly correlatedwith gold-standard lesion vol-
ume (Spearman's rho=0.08 p= 0.74), thepercentage of false negative
voxels had a signiﬁcant negative correlation with gold-standard lesion
volume (Spearman's rho = −0.63, p = 0.003), indicating that for
higher lesion volumes, there are less false negative voxels.
Finally, on native images on average 49.8% of the lesion area is quan-
tiﬁed as GM. After lesion-ﬁlling this percentage is highly improved:
when using the gold-standard, on average 0.4% of the LEAP-ﬁlled lesion
area is quantiﬁed as GM, and 24.5% of the FSL-lesion_ﬁlling ﬁlled lesion
area is quantiﬁed as GM (Fig. 3).
4. Discussion
This study demonstrates that when co-registered lesion masks from
2D images are used for lesion ﬁlling on 3DT1 images of patients with
MS, the quantitative GM volumes obtained are very similar to those
obtained using manually outlined 3D lesion masks.
Quantiﬁcation ofGMvolumeshas becomean important goal inMS re-
search and evaluation of therapeutic efﬁcacy. Without lesion ﬁlling, the
error in global GM volume can be substantial, but lesion ﬁlling reduces
this GM quantiﬁcation error (Battaglini et al., 2012; Nakamura and
Fisher, 2009; Sanﬁlipo et al., 2005). In the current study, this GM quanti-
ﬁcation error fromthenative images amounted to anaverage overestima-
tion of 0.3% and in individual cases was as high as 1%. These effects are
sizable in MS, where GM atrophy rates are approximately 0.2-0.6% per
year (Fisher et al., 2008). This conﬁrms the need for a practical solution
to this GM quantiﬁcation problem caused by the WM lesions.
However, despite technical developments in recent years, the lesion-
ﬁlling solution to atrophy quantiﬁcation inMS has so far not achieved its
full potential. An important reason is that in the absence of satisfactory
automated lesion segmentation methods (Garcia-Lorenzo et al., 2013;
Llado et al., 2012; Mortazavi et al., 2012), lesion-ﬁlling requires labor-
intensive precise manual outlining on high-resolution 3D images which
is usually prohibitively costly and this crucial practical aspect of the
method has so far received limited attention. The present study providesFig. 7. Percentage of greymatter (GM) segmented within the false negative and false positive v
with LEAP (left) and FSL-lesion-ﬁlling (right) as a function of the gold-standard lesion volume
negative voxels and in green with triangular markers the percentage of GM segmented withina viable solution to this problem, by demonstrating that lesion-ﬁlling
using co-registered lesion outlines from 2D images with the nearest
neighbor method (NNI) produces accurate volumetric results for global
GM andWM, as well as for DGM structures.
Among the interpolation methods for the registration of the lesion
masks, NNI most consistently provided volumetric results comparable
to gold-standard. This was visible with both lesion-ﬁlling methods,
indicating that our result is not lesion-ﬁlling method dependent.
Although the NNI masks do not overlap perfectly with the gold-
standard masks, they signiﬁcantly improve the GM segmentation, due
to changes in segmentation not only in the lesion area but also outside
of the lesion area (Fig. 6). Registering PDT2 lesion-masks proves as
expected not to be perfect, but a feasible approach for signiﬁcant
improvement in global GM volumetry when more precise lesion
masks are unavailable.
The white matter segmentation as well as the DGM segmentation
proved to be less sensitive to the inﬂuence of the lesions, as the results
before and after lesion-ﬁllingwith any lesionmaskwere not statistically
different. This is in contrastwith another study inMSwith a comparable
sample size and a lesion ﬁlling method similar to FSL-lesion_ﬁlling
where the DGM volumes were signiﬁcantly smaller after lesion ﬁlling
than before (Gelineau-Morel et al., 2012). Also in the study of Chard
et al. (2010) the white matter volume was signiﬁcantly increased after
lesion-ﬁlling. This may be due to the fact that our patients have a
relative low lesion load compared to these two studies. In light of the re-
sults of these studies, and recalling thatwith higher lesion loads the per-
centage of false negative lesional voxels compared to gold-standard
decreases, it is likely that the effect of lesion-ﬁlling using masks from
T2-weighted images will have a proportionally greater beneﬁcial effect
on brain segmentation as the brain lesion load increases.
Direct comparison of the two ﬁlling methods showed that signiﬁ-
cantly more voxels of the areas ﬁlled with FSL-lesion_ﬁlling were seg-
mented as GM than after ﬁlling with LEAP. FSL-lesion_ﬁlling uses
neighboring voxels for lesion-ﬁlling and as such the neighboring CSF
and GM intensities will also be used for ﬁlling, resulting in GM being
segmented within the lesion masks even after ﬁlling. On the other
hand the LEAP method does not account for the neighboring voxels,
which can create intensity differences between the ﬁlled lesions and
the surrounding WM, as visible in Fig. 3. In the current study, this
boundary did not have a negative effect on FSL-FAST or FSL-FIRST seg-
mentation, but it cannot be excluded that its presence may inﬂuence
other segmentation methods. This may also account for the segmenta-
tion of the FSL-lesion_ﬁlling images yielding results closer to the seg-
mentation of native images. Studies that utilize lesion-ﬁlling with
different software platforms should ideally assess the effect of
different lesion ﬁlling methods on the results.oxels of the images ﬁlled with nearest-neighbor registeredmasks (NNI) after lesion-ﬁlling
. In red with square markers is depicted the percentage of GM segmented within the false
the false positive voxels.
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MS research may misclassify lesion voxels as GM due to the labeling of
lesion voxels according to their intensities (fallingwithin the GM inten-
sity range) and the dependence on its neighbors (Smith et al., 2004).
Compared with the native images, the misclassiﬁcation within the le-
sion area is markedly improved by lesion-ﬁlling with both methods.
Still, the effect of lesion ﬁlling extends beyond the limits of the lesions
and inﬂuences thewhole GM segmentation, probably due to the chang-
es in thewhole image intensity histogram, used by FSL-FAST. This effect
was marked on GM areas outside lesions, in line with previous studies
(Chard et al., 2010; Gelineau-Morel et al., 2012) on simulated images.
Here we have conﬁrmed and quantiﬁed this effect on a multi-center
MSpatients' dataset. TheNNI registered lesionmasks used for lesionﬁll-
ing proved to markedly reduce these effects (both inside and outside
the lesion area) and produced results very similar to using gold standard
lesion masks.
Limitations: The data in this study consists of 20 patients from two
different sites, with different MRI acquisition protocols, including a dif-
ferent magnetic ﬁeld strength, and lesion outlining protocols. The fact
that GM quantiﬁcation using NNI co-registered lesion masks is accurate
across all images is an initial demonstration of the robustness of this ap-
proach. It suggests that the NNI registered lesion masks could also be
used for lesion ﬁlling inmulti-center studies, butmore research on larg-
er sample sizes is needed to conﬁrm this.
The gold-standard lesionmasks weremanually outlined on 3DT1 im-
ages by adjusting the contours of the 2D dual-echo lesion masks after
registering them to the 3DT1 images, and were not primarily drawn on
the 3DT1 images. Our aim was to include the same lesions in the gold-
standardmasks as in the registeredmask,which allowed the comparison
to be fair. Aiming for a practical and easy to use solution for lesion-ﬁlling
we have registered the 2D dual-echo lesion masks “as-is”, so no speciﬁc
correction has beenmade for regional DGMand cortical lesions. It cannot
be excluded that these lesions would inﬂuence the registration and
lesion-ﬁlling as well as the segmentation after lesion-ﬁlling, however
we did not see any difference in the DGM volumes before and after
lesion-ﬁlling, and we were also able to identify the NNI registration
method as being similar to gold-standard. Future studies should also in-
vestigate the inﬂuence of lesion location on lesion-ﬁlling.
5. Conclusion
Lesion-ﬁlling with MS lesion masks outlined on PDT2 images and
co-registered to 3DT1 images using nearest neighbor interpolation
yields accurate GM atrophy quantiﬁcation in MS. The proposed ap-
proach combines the high resolution of 3DT1 for atrophy quantiﬁcation,
and the time and cost efﬁciency of lesion outlining on 2D images.
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